THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT. (12th June 2019) - Burney, C.N.; Robinson, S.; Boumendil, A.; Finel, H.; Khvedelidze, I.; Hunter, H.; Poire, X.; Lioure, B.; Peggs, K.; Foa, R.; Pillai, S.; van Meerten, T.; et al.